Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.58 - $4.99 $46,047 - $89,061
-17,848 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$3.93 - $7.7 $4,940 - $9,678
-1,257 Reduced 6.58%
17,848 $70,000
Q4 2021

Feb 11, 2022

SELL
$7.1 - $12.82 $4,054 - $7,320
-571 Reduced 2.9%
19,105 $136,000
Q3 2021

Nov 12, 2021

SELL
$7.64 - $12.49 $1,604 - $2,622
-210 Reduced 1.06%
19,676 $216,000
Q2 2021

Aug 13, 2021

SELL
$8.68 - $27.49 $6,483 - $20,535
-747 Reduced 3.62%
19,886 $173,000
Q1 2021

May 07, 2021

BUY
$12.0 - $27.64 $12,264 - $28,248
1,022 Added 5.21%
20,633 $314,000
Q4 2020

Feb 12, 2021

SELL
$11.05 - $16.62 $6,221 - $9,357
-563 Reduced 2.79%
19,611 $229,000
Q3 2020

Nov 04, 2020

BUY
$11.69 - $14.54 $818 - $1,017
70 Added 0.35%
20,174 $257,000
Q2 2020

Aug 12, 2020

BUY
$9.75 - $17.6 $6,249 - $11,281
641 Added 3.29%
20,104 $300,000
Q1 2020

May 04, 2020

BUY
$7.54 - $17.05 $18,239 - $41,243
2,419 Added 14.19%
19,463 $225,000
Q4 2019

Feb 05, 2020

SELL
$6.71 - $9.55 $952 - $1,356
-142 Reduced 0.83%
17,044 $156,000
Q3 2019

Nov 08, 2019

BUY
$6.0 - $9.6 $2,568 - $4,108
428 Added 2.55%
17,186 $154,000
Q2 2019

Aug 13, 2019

BUY
$3.77 - $8.67 $63,177 - $145,291
16,758 New
16,758 $141,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $10.4M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.